THOMAS MOSER

Dr. Thomas Moser brings over 25 years of experience in venture financing, IP commercialization, venture capital, and innovative start-ups. He is the founder and CEO of Myllia Biotechnology and serves as CFO/COO of bit.bio discovery in Vienna. The company leverages an advanced CRISPR screening platform to identify novel therapeutic targets in partnership with leading pharmaceutical and biotech companies.